white crossTeva Pharmaceuticals USA Inc., Boehringer Ingelheim Pharmaceuticals, Inc., and other pharmaceutical companies are defendants in multidistrict litigation where it is alleged they engaged in a pay-for-delay scheme over the stroke drug Aggrenox.

Continue reading “Teva, Boehringer, and other pharmaceutical companies seek to dismiss indirect purchaser complaints”